1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2021 - Europe (p50)

Chronic Disease Analysis & Statistics 2021 - Europe (p50)

1471-1500 of about 1500 reports

Market Access Impact: Rheumatoid Arthritis (EU5) 2016

  • $ 5637
  • November 2016
  • 1 pages

Description Compare 10 major RA therapies. Find out if prescription barriers cost your brand market share In the EU5 countries, market barriers affect more than 15% of all rheumatoid arthritis (RA) ...

  • Spain
  • France
  • Arthritis
  • Monoclonal Antibody
  • Industry analysis

Europe Clot Management Devices Market (2016 - 2022)

  • $ 1500
  • January 2017
  • 65 pages

As per the World Health Organisation (WHO), more than 17 million people die annually from cardiovascular diseases. The main reason for cardiovascular diseases are increasing consumption of tobacco products, ...

  • Europe
  • France
  • Cardiovascular Disease
  • Blood Device
  • Industry analysis

UK Diabetes Market Report: 2017 - 2022

  • $ 1200
  • February 2017
  • 50 pages

IMARC’s new report “UK Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence, ...

  • United Kingdom
  • Diabetes
  • Industry analysis
  • Diabetes Prevalence

Bayer HealthCare AG - Medical Equipment - Deals and Alliances Profile, GlobalData

  • $ 250
  • April 2017
  • 27 pages

Summary Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group, is a healthcare company. It designs, researches, develops, manufactures and sells pharmaceuticals and consumer health products. ...

  • World
  • APAC
  • Healthcare
  • OTC
  • Company research
  • Company

Spinal Modulation Inc - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • April 2017
  • 19 pages

Summary Spinal Modulation Inc (SMI) a subsidiary of St. Jude Medical Inc is a medical device company that offers joint care products. The company develops therapies for chronic intractable leg pain, back ...

  • World
  • APAC
  • Medical Equipment
  • Chronic Pain
  • Company research
  • Company

Angionetics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • April 2017
  • 21 pages

Summary Angionetics Inc (Angionetics), a subsidiary of Taxus Cardium Pharmaceuticals Group Inc focuses on the development of treatments for myocardial ischemia and refractory angina. The company’s lead ...

  • APAC
  • Europe
  • Cardiovascular Disease
  • Pharmaceutical
  • Company research
  • Company

Afferent Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • April 2017
  • 17 pages

Summary Afferent Pharmaceuticals Inc (Afferent Pharmaceuticals) is a biopharmaceutical company that develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders. The ...

  • APAC
  • North America
  • Chronic Pain
  • Company research
  • Company

2017-2021 France Respiratory Diseases Diagnostic Testing Market

  • $ 1250
  • February 2017
  • 282 pages

About This ReportThis new 282-page report from VPGMarketResearch.com presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, ...

  • France
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 Germany Respiratory Diseases Diagnostic Testing Market

  • $ 1250
  • February 2017
  • 283 pages

About This ReportThis new 283-page report from VPGMarketResearch.com presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, ...

  • Germany
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 Italy Respiratory Diseases Diagnostic Testing Market

  • $ 1250
  • February 2017
  • 281 pages

About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, ...

  • Italy
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 Spain Respiratory Diseases Diagnostic Testing Market

  • $ 1250
  • February 2017
  • 281 pages

About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, ...

  • Spain
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 UK Respiratory Diseases Diagnostic Testing Market

  • $ 1250
  • February 2017
  • 281 pages

About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, ...

  • United Kingdom
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 France Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 1250
  • February 2017
  • 282 pages

About This ReportThis new 282-page report from VPGMarketResearch.com presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, ...

  • France
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 Germany Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 1250
  • February 2017
  • 283 pages

About This ReportThis new 283-page report from VPGMarketResearch.com presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, ...

  • Germany
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 Italy Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 1250
  • February 2017
  • 281 pages

About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, ...

  • Italy
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 Spain Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 1250
  • February 2017
  • 281 pages

About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, ...

  • Spain
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

2017-2021 UK Respiratory Diseases Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 1250
  • February 2017
  • 281 pages

About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, ...

  • United Kingdom
  • Diagnostics
  • Respiratory Disease
  • Industry analysis

Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Acute Coronary Syndrome patients study in a new report ‘Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017’. The report provides ...

  • World
  • Spain
  • Acute Coronary Syndrome
  • Industry analysis

Global Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Allergic Rhinitis patients study in a new report ‘Global Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • World
  • Spain
  • Respiratory Disease
  • Allergy Drug
  • Industry analysis

Global Atrial Fibrillation Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Atrial Fibrillation patients study in a new report ‘Global Atrial Fibrillation Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • World
  • Spain
  • Cardiovascular Disease
  • Industry analysis

Global Dyslipidemia Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Dyslipidemia patients study in a new report ‘Global Dyslipidemia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Dyslipidemia ...

  • World
  • Spain
  • Cholesterol
  • Industry analysis

Global Hypertension Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Hypertension patients study in a new report ‘Global Hypertension Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Hypertension ...

  • World
  • Spain
  • Hypertension
  • Industry analysis
  • Cardiovascular Disease Prevalence

Global Insomnia Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Insomnia patients study in a new report ‘Global Insomnia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Insomnia epidemiology, ...

  • World
  • Spain
  • Pharmaceutical
  • Sleep Aid
  • Industry analysis
  • Sleeping Disorders Prevalence

Global Osteoarthritis Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Osteoarthritis patients study in a new report ‘Global Osteoarthritis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Osteoarthritis ...

  • World
  • Spain
  • Arthritis
  • Industry analysis

Global Osteoporosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Osteoporosis patients study in a new report ‘Global Osteoporosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Osteoporosis ...

  • World
  • Spain
  • Musculoskeletal Disorder
  • Industry analysis

Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Rheumatoid Arthritis patients study in a new report ‘Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • World
  • Spain
  • Arthritis
  • Industry analysis
  • Auto-Immune Diseases Prevalence

Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Type 1 Diabetes patients study in a new report ‘Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • World
  • Spain
  • Type 1 Diabetes
  • Industry analysis

Global Type 2 Diabetes Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Type 2 Diabetes patients study in a new report ‘Global Type 2 Diabetes Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • World
  • Spain
  • Type 2 Diabetes
  • Industry analysis

Global Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Acute Heart Failure patients study in a new report ‘Global Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • World
  • Spain
  • Heart Failure
  • Industry analysis

Global Acute Ishemic Stroke Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Acute Ishemic Stroke patients study in a new report ‘Global Acute Ishemic Stroke Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • World
  • Spain
  • Stroke
  • Industry analysis

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on